PMID- 23110545 OWN - NLM STAT- MEDLINE DCOM- 20131105 LR - 20220311 IS - 1365-2060 (Electronic) IS - 0785-3890 (Print) IS - 0785-3890 (Linking) VI - 45 IP - 3 DP - 2013 May TI - Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans. PG - 220-9 LID - 10.3109/07853890.2012.732234 [doi] AB - AIM: Mast cells are important in experimental diabetes. Plasma levels of immunoglobulin E (IgE), tryptases, and chymases are inflammatory markers of human diabetes. Whether they also correlate with the risk of pre-diabetes, however, remains unknown. METHODS AND RESULTS: A total of 260 subjects 55-75 years of age were grouped as normal glucose tolerance (NGT), isolated impaired fasting glucose (I-IFG), isolated impaired glucose tolerance (I-IGT), and mixed IFG/IGT. There were significant differences in plasma levels of high-sensitivity C-reactive protein (hsCRP) (P < 0.001) and IgE (P = 0.003) among all subgroups of pre-diabetes, and chymase in I-IGT (P = 0.043) and mixed IFG/IGT (P = 0.037) subgroups compared with NGT group. High-sensitivity CRP was a risk factor in all subgroups of pre-diabetes; IgE was a risk factor of mixed IFG/IGT; and chymase was a risk factor of I-IGT and mixed IFG/IGT. Interactions between hsCRP and high waist circumference (WC), waist-to-hip ratio (WHR), or HOMA-beta index, and interactions between IgE and high WC or tryptase levels all increased further the risk of developing I-IFG, I-IGT, or mixed IFG/IGT. CONCLUSION: Plasma hsCRP, IgE, and chymase levels associate with pre-diabetes status. While hsCRP, IgE, and chymase are individual risk factors of pre-diabetes, interactions with metabolic parameters increased further the risk of pre-diabetes. FAU - Wang, Zhen AU - Wang Z AD - Department of Clinical Medicine, School of Medicine, Huzhou Teachers College , Huzhou, 313000, Zhejiang , China. FAU - Zhang, Hong AU - Zhang H FAU - Shen, Xu-Hui AU - Shen XH FAU - Jin, Kui-Li AU - Jin KL FAU - Ye, Guo-Fen AU - Ye GF FAU - Qiu, Wei AU - Qiu W FAU - Qian, Li AU - Qian L FAU - Li, Bo AU - Li B FAU - Zhang, Yong-Hong AU - Zhang YH FAU - Shi, Guo-Ping AU - Shi GP LA - eng GR - R01 HL060942/HL/NHLBI NIH HHS/United States GR - R01 HL081090/HL/NHLBI NIH HHS/United States GR - R01 HL088547/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121030 PL - England TA - Ann Med JT - Annals of medicine JID - 8906388 RN - 0 (Blood Glucose) RN - 37341-29-0 (Immunoglobulin E) RN - 9007-41-4 (C-Reactive Protein) RN - EC 3.4.21.39 (Chymases) RN - EC 3.4.21.59 (Tryptases) SB - IM MH - Aged MH - Blood Glucose/analysis MH - C-Reactive Protein/analysis MH - Chymases/*blood MH - Fasting MH - Female MH - *Glucose Tolerance Test MH - Homeostasis MH - Humans MH - Hypertension/epidemiology MH - Immunoglobulin E/*blood MH - Insulin-Secreting Cells/physiology MH - Logistic Models MH - Male MH - Middle Aged MH - Prediabetic State/*blood MH - Risk Factors MH - Sex Factors MH - Tryptases/*blood MH - Waist Circumference MH - Waist-Hip Ratio PMC - PMC3934348 MID - NIHMS552373 COIS- Declaration of interest: This work was supported by awards from the Huzhou Municipal Science and Technology Agency (2008GS09) (H.Z.), the Zhejiang Province Department of Health (2008B178) (Z.W.), and the Zhejiang Province Department of Education (20070470) (X.H.S.); by grants from the National Institutes of Health HL60942, HL81090, HL88547 (G.P.S.); and by an EIA award (0840118N) from the American Heart Association (G.P.S.). The authors report no conflicts of interest. EDAT- 2012/11/01 06:00 MHDA- 2013/11/06 06:00 PMCR- 2014/02/25 CRDT- 2012/11/01 06:00 PHST- 2012/11/01 06:00 [entrez] PHST- 2012/11/01 06:00 [pubmed] PHST- 2013/11/06 06:00 [medline] PHST- 2014/02/25 00:00 [pmc-release] AID - 10.3109/07853890.2012.732234 [doi] PST - ppublish SO - Ann Med. 2013 May;45(3):220-9. doi: 10.3109/07853890.2012.732234. Epub 2012 Oct 30.